Drop-out rates of cancer patients participating in longitudinal RCTs

Contemporary Clinical Trials

Volumn 28, Issue 4, 2007, Pages 340-342

  Mathibe, Lehlohonolo J ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; DOCETAXEL; ERYTHROPOIETIN;

AGE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CULTURAL FACTOR; DRUG EFFICACY; DRUG WITHDRAWAL; EDUCATIONAL STATUS; FINANCIAL MANAGEMENT; HEALTH CARE FACILITY; HUMAN; LETTER; LONGITUDINAL STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; PATIENT ABANDONMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; STATISTICAL CONCEPTS; UNSPECIFIED SIDE EFFECT;

AGE FACTORS; ANTINEOPLASTIC AGENTS; BIAS (EPIDEMIOLOGY); FEMALE; HUMANS; LONG-TERM CARE; MALE; NEOPLASMS; PATIENT DROPOUTS; RANDOMIZED CONTROLLED TRIALS; SEX FACTORS;

EID: 34248527650     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2007.03.006     Document Type: Letter

References (18)

1. Toulomi G., Babiker A.G., Pocock S.J., and Darbyshire J.H. Impact of missing data due to drop-outs on estimators of change in longitudinal studies: a simulation study. Stat Med 20 24 (2001) 3715-3728
2. Carpenter J., Pocock S., and Lamm C.J. Coping with missing data in clinical trials: a model-based approach applied to asthma trials. Stat Med 21 8 (2002) 1043-1066
3. Groen H.J.M., van der Leerst H.W., Fokkema E., Timmer P.R., Nossent G.D., Smit W.J., et al. Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small lung cancer: a multi-centre phase III study. Ann Oncol 15 (2004) 427-432
4. Burnstein H.J., Manola J., Younger J., et al. Docetaxel administered on a weekly basis for metastatic breast cancer. J Clin Oncol 18 6 (2000) 1212-1219
5. Mantovani G., Maccio A., Bianchi A., et al. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomised controlled trial. Cancer 77 5 (1996) 941-948
6. Spilker B. Methods of assessing and improving patient compliance in clinical trials. In: Spilker B. (Ed). Guide to clinical trials (1991), Raven Press, New York 102-104
7. Wright S.V. An Investigation into the causes of absconding among Black African breast cancer patients. S Afr Med J 87 11 (1997) 1540-1543
8. Goldhirsch A., Gelber R.D., Yothers G., Gray R.J., Green S., Bryant J., et al. Adjuvant therapy for very young women with breast cancer: need for tailored treatments. J Natl Cancer Inst Monographs 30 (2001) 44-50
9. Gelmon K., Eisenhauer E., Bryce C., Tolcher A., Mayer L., Tomlinson E., et al. Randomised phase II study of high-dose paclitaxel with or wihout amifostine in patients with metastatic breast cancer. J Clin Oncol 17 10 (1999) 3033-3047
10. Youssef G., and Links M. The Prevention and Management of Cardiovascular Complications of Chemotherapy in Patients with Cancer. Am J Cardiovasc Drugs 5 4 (2005) 233-243
11. Mathibe L.J., Szpak W., and Gray A. Comparison of two different antiemetic regimens in cancer patients receiving moderately emetogenic chemotherapy. Preliminary results presented at the 3rd International Pharmacology and Pharmaceutical Sciences Conference held at Boksburg, South Africa (2003)
12. Bloudes P. Drug compliance in therapeutic trials. Control Clin Trials 19 (1998) 257-268
13. Kirkwood B.R., and Sterne J.A.C. Essential medical statistics. 2nd ed (2003), Blackwell Science Ltd, Oxford
14. Llovet J.M., Fuster J., and Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 32 3 (2000) 679-680
15. Lachin J.M. Statistical considerations in the intent-to-treat principle. Control Clin Trials 21 3 (2000) 167-189
16. Kleinman K.P., Ibrahim J.G., and Laird N.M. A Bayesian framework for intent-to-treat analysis with missing data. Biometrics 54 1 (1998) 265-278
17. Fairclough D.L., Peterson H.F., and Chang V. Why are missing quality of life data a problem in clinical trials of cancer therapy?. Stat Med 17 5-7 (1998) 667-677
18. Ward E., King M., Lloyd M., Bower P., and Friedli K. Conducting randomised trials in general practice: methodological and practical issues. Br J Gen Pract 49 (1999) 919-922